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Scientific Abstract 
 
Little is known about the extent to which the healthcare needs of autistic older adults with 
intellectual disability (ID) differ from autistic older adults without ID. We conducted a cross-
sectional retrospective cohort study of Medicare claims data from 2016-2017 to compare the 
prevalence of physical and mental health conditions among autistic older adults (age 65+ years) 
with ID (N=2,054) to autistic older adults without ID (N=2,631). Medicare claims data consisted 
of records from inpatient hospitalizations and institutional outpatient visits (i.e., visits to hospital 
outpatient departments, rural health clinics, renal dialysis facilities, outpatient rehabilitation 
facilities, Federally Qualified Health Centers, and community mental health centers). 
Examination of the largest between-group differences revealed that autistic older adults with ID 
had 350% greater odds of epilepsy (OR=4.5, 95% CI=3.9-5.2), 170% greater odds of 
osteoporosis (OR=2.7, 95% CI=2.3-3.2), and 100% greater odds of gastrointestinal conditions 
(OR=2.0, 95% CI=1.8-2.2) but 80% lower odds of attention deficit disorders (OR=0.2, 95% 
CI=0.1-0.3), 70% lower odds of substance use disorders (OR=0.3, 95% CI=0.2-0.4), and 60% 
lower odds of suicidal ideation or intentional self-injury (OR=0.4, 95% CI=0.3-0.6). These 
findings highlight the importance of developing tailored health management strategies for the 




Little is known about the extent to which the healthcare needs of autistic older adults with 
intellectual disability (ID) differ from autistic older adults without ID. Our study is the first, to our 
knowledge, to use United States national data to compare physical and mental health conditions 
among autistic older adults with and without ID. The data analyzed in this study consisted of 
records from inpatient hospitalizations as well as ‘institutional outpatient’ healthcare visits, which 
includes visits to hospital outpatient departments, rural health clinics, renal dialysis facilities, 
outpatient rehabilitation facilities, Federally Qualified Health Centers, and community mental 
health centers. Autistic older adults with ID were significantly more likely to have: thyroid 
disorders, epilepsy, respiratory infections, gastrointestinal conditions, osteoporosis, cognitive 
disorders, and schizophrenia/psychotic disorders. In contrast, autistic older adults without ID 
were significantly more likely to have: obesity, diabetes, high blood pressure, cerebrovascular 
disease, chronic obstructive pulmonary disease, arthritis, back conditions, attention deficit 
disorders, substance use disorders, and suicidal ideation or intentional self-injury. These 
findings highlight the importance of developing distinct, tailored health management strategies 
for the autistic older adults with and without ID.   
Introduction 
Relatively little is known about the health status of autistic adults over the age of 65. 
Much of what is known about this population comes from self-report studies, which exclude 
individuals for whom surveys are inaccessible (van Heijst & Geurts, 2015) , or studies with 
limited generalizability due to restriction to a single geographic region (Bishop-Fitzpatrick & 
Rubenstein, 2019; Lever & Geurts, 2016). Other studies combine data from autistic adults over 
the age of 65 years together with younger age groups, which makes it challenging to distinguish 
the unique needs of this older population (Bishop-Fitzpatrick & Rubenstein, 2019; de Winter et 
al., 2012). The lack of studies in this area creates a great deal of uncertainty for autistic adults, 
their loved ones, and healthcare systems concerning how best to anticipate and meet this 
population’s needs as they age (Bishop-Fitzpatrick & Rubenstein, 2019; Kats et al., 2013; Piven 
& Rabins, 2011).   
To help address this gap in knowledge, United States national data was used in a recent 
study to compare the prevalence of physical and mental health conditions among autistic older 
adults (age 65+ years) to a population comparison group (Hand et al., 2020). Results revealed 
that autistic older adults were more likely than the population comparison group to be diagnosed 
with almost all physical and mental health conditions examined. However, the extent to which 
the physical and mental health conditions for which older autistic adults require care differs 
based on intellectual disability remains unclear.  
Studies of younger populations of autistic individuals have found that the healthcare 
needs of those with and without co-occurring intellectual disability (ID) tend to differ. For 
example, some studies have found autistic individuals without co-occurring ID are more likely to 
have mental health conditions like depression, anxiety, and suicidal ideation than autistic 
individuals with ID (Camm-Crosbie et al., 2018; Hand et al., 2019; Strang et al., 2012). Other 
studies have found that autistic individuals with ID are more likely than those without ID to have 
epilepsy (Berg & Plioplys, 2012) or obesity (Rimmer et al., 2010). Additionally, there is some 
evidence to suggest that autistic adults with ID over the age of 40 may be more likely than 
same-aged autistic adults without ID to have neurologic and gastrointestinal disorders (Bishop-
Fitzpatrick & Rubenstein, 2019).  
Further research is critical for understanding the specific needs of older autistic adults 
with and without co-occurring ID to inform autism community members, policy makers, 
healthcare delivery systems, and healthcare providers. The purpose of this study, therefore, 
was to compare the prevalence of physical and mental health conditions among a national 
sample of older autistic adults with and without co-occurring ID. We hypothesized that autistic 
adults with and without co-occurring ID would significantly differ on the prevalence of mental 
and physical health conditions. Specifically, based on prior literature, we hypothesized that 
mental health conditions would be more common among autistic older adults without ID, while 
autistic older adults with ID would be more likely to have physical health conditions like epilepsy, 
gastrointestinal conditions, and obesity.  
Methods 
Data Source 
 We analyzed beneficiary-level inpatient and outpatient healthcare claims data from 
Medicare Standard Analytic Files (SAF), which include Limited Data Set information on 100% of 
Medicare beneficiaries for the years 2016-2017. One unique benefit of this data source is that it 
allows us to study a large, national sample of individuals without the need for prospective data 
collection. The SAF outpatient records contained medical billing claims from institutional 
outpatient providers (i.e., hospital outpatient departments, rural health clinics, renal dialysis 
facilities, outpatient rehabilitation facilities, Federally Qualified Health Centers, and community 
mental health centers) but did not include professional service claims from non-institutional 
professional providers such as physicians, physician assistants, clinical social workers, or nurse 
practitioners.  
Study Population  
 Autistic adults were included in this study if they: 1) were aged 65 years or older; 2) were 
enrolled in Medicare Fee for Service for at least 6 consecutive months in 2016 or 2017; and 3) 
had at least one inpatient or outpatient encounter with an autism spectrum disorder (ASD) 
diagnosis at any time during January 1st, 2016 – December 31st, 2017. Requiring only one 
ASD diagnosis has been shown to be appropriate for identifying autistic individuals in Medicare 
claims (Benevides et al., 2019) and has been used in prior studies of healthcare claims data 
(e.g., (Benevides et al., 2020; Hand et al., 2020; Leslie & Martin, 2007; Maddox et al., 2018). 
ASD diagnoses were identified using International Classification of Diseases, 10th edition (ICD-
10) codes F84.0, F84.1, F84.5, or F84.9.  
We excluded beneficiaries enrolled in Medicare Advantage Plans due to concerns 
regarding the availability of accurate, complete data (Demiralp et al., 2019; Lankiewicz et al., 
2018; Mahr et al., 2018). We also excluded Medicare-enrolled autistic adults under the age of 
65 years. Although recent expert-opinions suggest that autistic individuals should be considered 
older adults at age 50 years (Roestorf et al., 2019), we chose to keep the more conventional 
cut-off of 65 years of age due to Medicare eligibility rules. Most Medicare beneficiaries are 
entitled to coverage based on their age (i.e., any US citizen or permanent resident over the age 
of 65 years). In contrast, individuals under the age of 65 years can also qualify for Medicare, but 
only with a formal disability ruling by the Social Security Administration. As Medicare 
beneficiaries under the age of 65 years may differ in meaningful ways from individuals who 
qualify for Medicare on the basis of age, we made the methodologic choice that would result in 
the most homogeneous study sample.  
After identifying all eligible autistic older adults, we classified the beneficiaries into two 
groups – 1) autistic older adults with a co-occurring ID diagnosis and 2) autistic older adults 
without a co-occurring ID diagnosis. Intellectual disability was identified based on at least one 
medical encounter with an ICD-10 code of F70-F79.  
Measures 
 We identified mental and physical health conditions using the Healthcare Cost and 
Utilization Project (HCUP) Beta Multilevel Clinical Classification Software (CCS) for ICD-10 
(HCUP, 2016). HCUP Beta CCS groups diagnostic codes from the medical billing record into a 
smaller number of clinically meaningful categories. We also identified some mental and physical 
health conditions, including obesity, menopausal disorders, Parkinson’s disease, multiple 
sclerosis, sleep disorders, and attention deficit hyperactivity disorders, based on the presence of 
specific ICD-10 codes. We provided a list of the physical and mental health conditions we 
examined and how each was defined in Supplementary Table 1.  
Statistical Analysis 
 Demographic characteristics were summarized descriptively. Separate logistic 
regression models were performed to compare older autistic adults with and without co-
occurring ID on the odds of each condition while controlling for sex, race/ethnicity, age, rural 
residence, estimated household income, and duration (months) of observation. Race and 
ethnicity were categorized as white non-Hispanic, black non-Hispanic, Hispanic, and 
other/unknown. Rural residence was defined by living in a non-metropolitan statistical area. 
Household incomes were estimated for each beneficiary using the median per capita household 
income during 2017, among individuals over 65 years of age, for the beneficiary’s county of 
residence. Duration of observation was defined as the number of months during 2016 and 2017 
that the individual was enrolled in Medicare. Odds ratios were interpreted according to Agresti 
(2013). Additionally, we performed a sensitivity analysis to determine the extent to which our 
results were influenced by our inclusion criteria (i.e., inclusion of autistic adults with at least one 
inpatient or one outpatient encounter with a diagnosis of autism). To examine this, we replicated 
our analyses with only the subset of beneficiaries who met a more stringent inclusion criteria of 
at least one inpatient or two outpatient encounters with a diagnosis code for autism. We used 
SAS statistical software, version 9.4 for all analyses.  
Ethical Approval 
 The Institutional Review Board (IRB) of the [Removed for Blinding] University reviewed 
this study and determined it to be IRB-exempt due to the use of limited datasets.  
Results 
A total of 4,685 autistic older adults met the inclusion criteria for this analysis. 
Demographic information for included beneficiaries is provided in Table 1. Most beneficiaries 
were male, aged 65-69 years old, and white. Approximately 19% of autistic older adults with an 
ID and 21% of those without ID resided in rural areas. Most beneficiaries resided in the 
Southern or Northeastern United States.   
Table 2 provides information on the prevalence of physical and mental health conditions 
among autistic older adults with and without co-occurring ID. After adjusting for sex, age, 
race/ethnicity, rural residence, and estimated household income, significant differences between 
groups were observed in the odds of having most physical and mental health conditions. 
Specifically, relative to autistic older adults without ID, those with co-occurring ID had: 350%  
greater odds of epilepsy (OR=4.5, 95% CI=3.9-5.2); 170% greater odds of osteoporosis 
(OR=2.7, 95% CI=2.3-3.2); 100% greater odds of other gastrointestinal disorders (OR=2.0, 95% 
CI=1.8-2.2); 80% greater odds of respiratory infections (OR=1.8, 95% CI=1.6-2.1); 50% greater 
odds of thyroid disorders (OR=1.5, 95% CI=1.3-1.7); 50% greater odds of upper or lower 
gastrointestinal disorders (OR=1.5, 95% CI=1.3-1.7); 40% greater odds of cognitive disorders 
(OR=1.4, 95% CI=1.2-1.6); and 30% greater odds of schizophrenia/psychotic disorders 
(OR=1.3, 95% CI=1.1-1.6).  
However, autistic older adults with ID had significantly lower odds of: attention deficit 
disorders (ADD) (80% lower odds; OR=0.2, 95% CI=0.1-0.3), substance use disorders (70% 
lower odds; OR=0.3, 95% CI=0.2-0.4), suicidal ideation or intentional self-injury (60% lower 
odds; OR=0.4, 95% CI=0.3-0.6), back conditions (50% lower odds; OR=0.5, 95% CI=0.4-0.6), 
obesity (30% lower odds; OR=0.7, 95% CI=0.6-0.8), diabetes (30% lower odds; OR=0.7, 95% 
CI=0.6-0.8), cerebrovascular disease (30% lower odds; OR=0.7, 95% CI=0.6-0.9), high blood 
pressure (20% lower odds; OR=0.8, 95% CI=0.7-0.9), chronic obstructive pulmonary disease 
(20% lower odds; OR=0.8, 95% CI=0.7-0.9), and arthritis (20% lower odds; OR=0.8, 95% 
CI=0.7-0.9). 
Sensitivity Analysis 
 Supplementary Table 2 summarizes demographic information about the subset of 
beneficiaries who were included in our sensitivity analyses. A total of 3,388 beneficiaries 
(N=1,594 with co-occurring ID; N=1,794 without co-occurring ID) met the more stringent 
inclusion criteria, requiring at least one inpatient or two outpatient encounters with an autism 
diagnosis. Supplementary Table 3 provides information on the prevalence of physical and 
mental health conditions among this subset of beneficiaries. Overall, logistic regression results 
comparing the odds of physical and mental health conditions among the subsets of autistic older 
adults with and without ID were consistent with those presented in Table 3. One exception is 
that, in this sensitivity analysis, autistic older adults with and without co-occurring ID did not 
significantly differ in the odds of diabetes (OR=1.1; 95% CI=0.6-2.0).  
Discussion 
 The present study constitutes the first US nation-wide analysis of the prevalence of 
health conditions among autistic adults over 65 years of age, stratified by intellectual disability. 
Results of this study suggest that autistic older adults with and without ID significantly differ on 
the prevalence of many physical and mental health conditions. The findings of this work have 
important implications for healthcare providers, healthcare systems, and policy makers. For 
example, these findings speak to the need to develop tailored health management strategies for 
autistic older adults as a function of co-occurring ID due to differences in the prevalence of 
many conditions. Additionally, by characterizing the healthcare needs of autistic adults as they 
age using a large, national sample, this study addresses a priority area identified by the 
Interagency Autism Coordinating Committee’s 2016-2017 strategic plan (IACC, 2017), which is 
used to inform funding priorities for federal activities related to autism. Our results can help 
inform future funding priorities to develop innovative, patient-centered solutions to better meet 
the healthcare needs autistic older adults with and without ID.  
When interpreting our findings, it is important to acknowledge that beneficiaries included 
in this study were selected based on medical billing records from inpatient hospitalizations or 
institutional outpatient visits. Institutional outpatient visits include visits to hospital outpatient 
departments, rural health clinics, community health centers, renal dialysis facilities, and 
outpatient rehabilitation facilities. These settings likely did not capture all eligible autistic older 
adults, as individuals may have received care outpatient care in non-institutional settings from 
professional providers such as physicians, physician assistants, clinical social workers, and 
nurse practitioners. As a result, it is possible that some Medicare-enrolled autistic older adults 
were not included in this study. Additionally, it is possible that the autistic older adults who were 
included in this study visited non-institutional outpatient facilities for mental or physical 
healthcare, which indicates that our findings likely represent a conservative estimate of the 
prevalence of mental and physical health conditions in this population.   
It is also important to acknowledge that the results of this study apply only to those 
autistic adults who are currently 65 years of age or older and may not be predictive of the health 
needs of future generations of autistic older adults. For example, our inclusion of only 
individuals who lived past 65 years introduces survivorship bias, particularly as autistic adults 
may be at elevated risk for premature mortality (Hirvikoski et al., 2016). As such, our findings 
generalize only to those autistic adults who live past the age of 65, a population that may be 
meaningfully different from those autistic adults who do not live past the age of 65 years. 
Additionally, all Medicare beneficiaries included in this study were born before the year 1950, 
which was before autism was an official diagnosis (1980) in the Diagnostic and Statistical 
Manual of Mental Disorders III (DSM-III) and revisions were made to the diagnostic criteria for 
autism in the DSM-IV (1994) and DSM-5 (2013). These beneficiaries also did not have the 
protections afforded to subsequent generations by the Americans with Disabilities Act (1990) 
and the Individuals with Disabilities Education Act (1990) during their formative years. As such, 
this sample likely includes autistic individuals with different health-related needs than current 
pediatric or younger adult samples. Nevertheless, the findings of this study have important 
implications for the healthcare of autistic older adults living in the United States today. 
Indeed, comparing our findings to those of prior studies suggests that autistic older 
adults represent a unique subgroup with healthcare needs that are distinct from younger 
populations of autistic adults or older adults with ID. In examining the prevalence of physical and 
mental health conditions among our total sample, the autistic older adults in this study had a 
higher prevalence of most health conditions than has been found in prior studies of autistic 
adults (Croen et al., 2015) or adults with ID (Hussain et al., 2020; McCarron et al., 2017; Cooper 
et al., 2015). For example, the prevalence of diabetes and hypertension in our sample were 
36.6% and 66.5%, while Croen et al. (2015) found prevalence rates among autistic adults of 
7.6% and 25.6%, respectively. This higher prevalence is likely explained by the older age of 
individuals included our sample, as Croen et al.’s (2015) study was comprised almost 
exclusively of individuals aged 18-64 years. However, our sample did have a lower prevalence 
of a select few health conditions compared to that of Croen et al. (2015) such as obesity (14.4% 
vs 33.9%), asthma (9.1% vs 12.5%), ADD (2.5% vs 12.0%) and sleep disorders (1.4% vs 
17.6%). Relative to prior studies on the prevalence of conditions among adults with ID aged 60+ 
years (Hussain et al., 2020), our sample of autistic older adults had a higher prevalence of a 
number of conditions including diabetes (36.6% vs 25.6%), heart disease (54.2% vs 14.9%), 
hypertension (66.5% vs 8.7%), and anxiety (37.2% vs 22.0%) but lower prevalence of other 
conditions such as asthma (9.1% vs 16.1%) and arthritis (36.4% vs 40.4%).  
Several of our findings, however, are consistent with the broader literature about the 
physical and mental health of younger populations of autistic individuals. For example, co-
occurring ID is significantly associated with gastrointestinal conditions among autistic individuals 
aged 1-53 years (Penzol et al., 2019) and osteoporosis among autistic individuals over 40 years 
of age 3/26/21 9:36:00 PM. Additionally, the link between autism, ID, and epilepsy has been 
well-documented in pediatric samples (Anand & Jauhari, 2019; Berg & Plioplys, 2012). While 
the mechanisms that link these conditions are not well-understood, literature points to likely 
factors such as shared genetic underpinnings and similar biological processes (Lee et al., 
2015). In part, the common co-occurrence of autism, ID, and epilepsy may explain our finding of 
increased prevalence of osteoporosis among autistic older adults with ID, as anti-seizure 
medications are a known risk factor for osteoporosis (Srikanth et al., 2011).  
Similar to other published studies, we also found that ADD was more common among 
autistic adults without ID 3/26/21 9:36:00 PM. One possible explanation for this finding may be 
that, among those with ID, ADDs may be more difficult to diagnose due to diagnostic 
overshadowing (Al-Khudairi et al., 2019). The higher prevalence of ADDs among autistic older 
adults without ID may also explain the increased risk of substance use disorders among this 
group, as prior studies have shown that substance use disorders are most common among 
autistic adults who have a co-occurring ADD diagnosis (Butwicka et al., 2017).  
Finally, our results echo the need for better methods of detecting of suicidality among 
autistic individuals. Autistic older adults have 15 times greater odds of suicidal ideation and 
intentional self-injury, and autistic adults have 5 times greater odds of suicide attempts than 
general older adult and adult populations, respectively (Croen et al., 2015; Hand et al., 2020). In 
this study, autistic older adults without co-occurring ID were significantly more likely to have a 
medical encounter for suicidal ideation or intentional self-inflicted injury than those with a co-
occurring ID. This finding may be related to evidence that absence of an intellectual disability is 
associated with higher rates of depression among autistic individuals (Buck et al., 2014; 
Greenlee et al., 2016), and depression is a well-established risk factor for suicidal ideation 
(Mayes et al., 2013; Stewart et al., 2017; Taliaferro & Muehlenkamp, 2014). Our findings, 
therefore, add to a growing body of literature on factors associated with increased risk of 
suicidality among autistic individuals (e.g., Cassidy et al., 2018; Hand et al., 2019; Kirby et al., 
2019).  
Methodologic Considerations and Future Directions 
Several additional methodologic factors are crucial to acknowledge for this study and 
should be considered when interpreting our results. We could not control for variables such as 
socioeconomic status, social support, and perceived met/unmet healthcare needs, and these 
may be strongly associated with the prevalence of the conditions that we examined. 
Additionally, the diagnostic codes found in the medical claims data that we used for this study 
carry with them possible bias; accurate diagnoses can be challenging for providers to obtain for 
patients who have barriers to communication, and providers themselves may have their own 
biases that influence their diagnostic decision making. This study did not examine longitudinal 
change in the occurrence of physical and mental health conditions, but this will be important to 
examine in future work. Finally, eligible autistic older adults who did not seek treatment for 
physical and mental health conditions or who were underdiagnosed were also not captured in 
this study. Despite these methodological factors, this work provides an impactful contribution to 
the literature and may aid clinicians in provision of informed healthcare for autistic older adults 
with and without ID. 
Conclusion 
This research offers valuable insight into the distinct physical and mental health 
conditions for which Medicare-enrolled autistic older adults with and without ID require care. 
Further research is warranted to understand change in condition prevalence over time and the 
underlying mechanisms that contribute to differences in the prevalence of physical and mental 
health conditions between autistic older adults with and without ID. The findings of this work 
further support the need for comprehensive, patient-centered healthcare for this population to 
best meet their unique needs.   
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Table 1: Demographic characteristics of autistic older adult Medicare beneficiaries with 
and without co-occurring intellectual disability  
 






Male, n (%) 3175 (67.8)  1414 (68.8) 1761 (66.9) 
Age, n (%)     
     65-69 2442 (52.1)  1196 (58.2) 1246 (47.4) 
     70-74 1190 (25.4)  528 (25.7) 662 (25.2) 
     75-79 541 (11.5)  192 (9.3) 349 (13.3) 
     80-84 300 (6.4)  102 (5.0) 198 (7.5) 
     >84 212 (4.5)  36 (1.8) 176 (6.7) 
US region, n (%)     
     South 1532 (32.7)  557 (27.1) 975 (37.1) 
     Northeast 1216 (26.0)  589 (28.7) 627 (23.8) 
     Midwest 931 (19.9)  445 (21.7) 486 (18.5) 
     West 511 (10.9)  216 (10.5) 295 (11.2) 
     Unknown 495 (10.6)  247 (12.0) 248 (9.4) 
Race, n (%)     
     White, non-Hispanic 4164 (88.9)  1824 (88.8) 2340 (88.9) 
     Black, non-Hispanic 331 (7.1)  182 (8.9) 149 (5.7) 
     Hispanic 34 (0.7)  14 (0.7) 20 (0.8) 
     Other or unknown 156 (3.3)  34 (1.7) 122 (4.6) 
Rural,a n (%) 930 (19.9)  386 (18.8) 544 (20.7) 
Household income,  
Median (IQR)b 
31 (10, 83)  29 (10, 85) 35 (10, 82) 
Duration (months) of 
observation, Median (IQR) 
24 (24, 24)  24 (24, 24) 24 (24, 24) 
aRural residence was defined as living in a non-metropolitan statistical area 
bReported in thousands of 2017 United States Dollars  




Table 2: Prevalence of physical and mental health conditions among autistic older 














Physical Health     
     Metabolic Disorders     
          Diabetes 1715 (36.6) 648 (31.5) 1067 (40.6) 0.7 (0.6-0.8) 
          Obesity 676 (14.4) 259 (12.6) 417 (15.8) 0.7 (0.6-0.8) 
          Thyroid Disorders 1485 (31.7) 741 (36.1) 744 (28.3) 1.5 (1.3-1.7) 
     Menopausal Disorders 62 (1.3) 30 (1.5) 32 (1.2) 1.2 (0.7-2.0) 
     Cancer 1440 (30.7) 586 (28.5) 854 (32.5) 0.9 (0.8-1.0) 
     Nervous System Diseases     
          Epilepsy 1239 (26.4) 876 (42.6) 363 (13.8) 4.5 (3.9-5.2) 
          Parkinson's Disease 308 (6.6) 147 (7.2) 161 (6.1) 1.3 (1.0-1.6) 
          Multiple Sclerosis 16 (0.3) 5 (0.2) 11 (0.4) 0.6 (0.2-1.7) 
     Circulatory Conditions     
          Hypertension 3115 (66.5) 1287 (62.7) 1828 (69.5) 0.8 (0.7-0.9) 
          Heart Disease 2538 (54.2) 1055 (51.4) 1483 (56.4) 0.9 (0.8-1.1) 
          Cerebrovascular Disease 568 (12.1) 200 (9.7) 368 (14) 0.7 (0.6-0.9) 
     Respiratory Conditions     
          Respiratory Infections 1493 (31.9) 785 (38.2) 708 (26.9) 1.8 (1.6-2.1) 
          COPD 819 (17.5) 307 (14.9) 512 (19.5) 0.8 (0.7-0.9) 
          Asthma 426 (9.1) 168 (8.2) 258 (9.8) 0.8 (0.7-1.0) 
          Other (e.g., Pleurisy, Respiratory 
Failure) 2387 (50.9) 
1143 (55.6) 1244 (47.3) 1.5 (1.3-1.7) 
     Gastrointestinal (GI) Conditions     
         Upper or Lower GI Disorders 2275 (48.6) 1097 (53.4) 1178 (44.8) 1.5 (1.3-1.7) 
         Other (e.g., Gastroenteritis, Constipation) 2400 (51.2) 1230 (59.9) 1170 (44.5) 2.0 (1.8-2.2) 
     Musculoskeletal     
         Arthritis 1705 (36.4) 676 (32.9) 1029 (39.1) 0.8 (0.7-0.9) 
         Back Conditionsb 917 (19.6) 280 (13.6) 637 (24.2) 0.5 (0.4-0.6) 
         Osteoporosis 780 (16.6) 480 (23.4) 300 (11.4) 2.7 (2.3-3.2) 
     Injuries     
         Fractures 718 (15.3) 368 (17.9) 350 (13.3) 1.5 (1.3-1.8) 
         Poisoning  106 (2.3) 51 (2.5) 55 (2.1) 1.0 (0.7-1.5) 
Mental Health     
     Mood Disorders 1680 (35.9) 693 (33.7) 987 (37.5) 0.8 (0.7-1.0) 
     Anxiety Disordersc 1743 (37.2) 775 (37.7) 968 (36.8) 1.0 (0.9-1.1) 
     Personality Disorders 146 (3.1) 55 (2.7) 91 (3.5) 0.7 (0.5-1.0) 
     Suicidal Ideation or Intentional Self-Injury 168 (3.6) 47 (2.3) 121 (4.6) 0.4 (0.3-0.6) 
     Substance Use Disorders 430 (9.2) 92 (4.5) 338 (12.8) 0.3 (0.2-0.4) 
     Schizophrenia and Psychotic Disorders 833 (17.8) 424 (20.6) 409 (15.5) 1.3 (1.1-1.6) 
     Cognitive Disordersd 1181 (25.2) 535 (26) 646 (24.6) 1.4 (1.2-1.6) 
     Sleep Disorders  67 (1.4) 29 (1.4) 38 (1.4) 1.0 (0.6-1.6) 
     Attention Deficit Disorders  116 (2.5) 16 (0.8) 100 (3.8) 0.2 (0.1-0.3) 
aAdjusted for sex, age, race/ethnicity, rural residence, estimated household income, and duration of 
observation 
bIncludes spondylosis, intervertebral disc disorders, and “other” back problems  
cIncludes obsessive compulsive disorders, generalized anxiety disorder, phobias, post-traumatic stress 
disorder, and other anxiety disorders 
dIncludes delirium, dementia, amnesia, and “other” cognitive disorders 






Supplementary Table 1: Study definitions of mental and physical health conditions using 
Healthcare Cost and Utilization Project (HCUP) Beta Multilevel Clinical Classification 
Software (CCS) or specific International Classification of Diseases, 10th edition (ICD-10) 
diagnosis codes 
 
Condition HCUP CCS Level(s) ICD-10 Code 
Physical Health   
     Metabolic Disorders   
          Diabetes 3.2-3.3  
          Obesity  E66.XX 
          Thyroid Disorders 3.1  
     Menopausal Disorders  E28.31, N95 
     Cancer 2  
     Nervous System Diseases   
          Epilepsy 6.4  
          Parkinson's Disease  G20 
          Multiple Sclerosis  G35 
     Circulatory Conditions   
          Hypertension 7.1  
          Heart Disease 7.2  
          Cerebrovascular Disease 7.3  
     Respiratory Conditions   
          Respiratory Infections 8.1  
          COPD 8.2  
          Asthma 8.3  
          Other (e.g., Pleurisy, Respiratory Failure) 8.4-8.9  
     Gastrointestinal (GI) Conditions   
         Upper or Lower GI Disorders 9.4, 9.6  
         Other (e.g., Gastroenteritis, Constipation) 9.11, 9.12  
     Musculoskeletal   
         Arthritis 13.1, 13.2  
         Back Conditionsa 13.3  
         Osteoporosis 13.4  
     Injuries   
         Fractures 16.2  
         Poisoning  16.11  
Mental Health   
     Mood Disorders 5.8  
     Anxiety Disorders 5.2  
     Personality Disorders 5.9  
     Suicidality or Intentional Self-Injury 5.13  
     Substance Use Disorders 5.11, 5.12  
     Schizophrenia and Psychotic Disorders 5.10  
     Cognitive Disordersb 5.4  
     Sleep Disorders    F51.XX 
     Attention Deficit Disorders   F90.XX 
 
aIncludes delirium, dementia, amnesia, and “other” cognitive disorders 
bIncludes spondylosis, intervertebral disc disorders and “other” back problems  
 
Abbreviations: COPD = Chronic obstructive pulmonary disease  
Additional information about the HCUP Beta Multilevel CCS for ICD-10 can be located 





Supplementary Table 2: Demographic characteristics of the subset of autistic older adult 
Medicare beneficiaries with at least one inpatient or two outpatient encounters with an 
autism diagnosis 
 






Male, n (%) 2389 (70.5) 1119 (70.2) 1270 (70.8) 
Age, n (%)    
     65-69 1804 (53.2) 946 (59.3) 858 (47.8) 
     70-74 845 (24.9) 388 (24.3) 457 (25.5) 
     75-79 385 (11.4) 152 (9.5) 233 (13.0) 
     80-84 205 (6.1) 80 (5.0) 125 (7.0) 
     >84 149 (4.4) 28 (1.8) 121 (6.7) 
US region, n (%)    
     South 1145 (33.8) 692 (38.6) 453 (28.4) 
     Northeast 886 (26.2) 429 (23.9) 457 (28.7) 
     Midwest 661 (19.5) 321 (17.9) 340 (21.3) 
     West 351 (10.4) 196 (10.9) 155 (9.7) 
     Unknown 345 (10.2) 156 (8.7) 189 (11.9) 
Race, n (%)    
     White, non-Hispanic 3019 (89.1) 1417 (88.9) 1602 (89.3) 
     Black, non-Hispanic 230 (6.8) 139 (8.7) 91 (5.1) 
     Hispanic 24 (0.7) 11 (0.7) 13 (0.7) 
     Other or unknown 115 (3.4) 27 (1.7) 88 (4.9) 
Rural,a n (%) 601 (17.7) 271 (17.0) 330 (18.4) 
Household income,  
Median (IQR)b 
31 (11, 83) 29 (11, 83) 34 (11, 83) 
Duration (months) of 
observation, Median (IQR) 
24 (24, 24) 24 (24, 24) 24 (24, 24) 
aRural residence was defined as living in a non-metropolitan statistical area 
bReported in thousands of 2017 United States Dollars  
Abbreviations: ID = Intellectual disability; IQR = Interquartile range 
 
  
Supplementary Table 3: Prevalence of physical and mental health conditions among the 
subset of autistic older adults with at least one inpatient or two outpatient encounters 














Physical Health     
     Metabolic Disorders     
          Diabetes 1296 (38.3) 521 (32.7) 775 (43.2) 1.1 (0.6-2.0) 
          Obesity 523 (15.4) 216 (13.6) 307 (17.1) 0.7 (0.6-0.8) 
          Thyroid Disorders 1083 (32.0) 585 (36.7) 498 (27.8) 1.6 (1.4-1.9) 
     Menopausal Disorders 41 (1.2) 21 (1.3) 20 (1.1) 1.1 (0.6-2.0) 
     Cancer 1060 (31.3) 467 (29.3) 593 (33.1) 0.9 (0.7-1.0) 
     Nervous System Diseases     
          Epilepsy 966 (28.5) 695 (43.6) 271 (15.1) 4.2 (3.5-4.9) 
          Parkinson's Disease 225 (6.6) 124 (7.8) 101 (5.6) 1.5 (1.1-2.0) 
          Multiple Sclerosis 10 (0.3) 3 (0.2) 7 (0.4) 0.5 (0.1-1.9) 
     Circulatory Conditions     
          Hypertension 2324 (68.6) 1026 (64.4) 1298 (72.4) 0.7 (0.6-0.9) 
          Heart Disease 1980 (58.4) 886 (55.6) 1094 (61) 0.9 (0.8-1.1) 
          Cerebrovascular Disease 445 (13.1) 85 (5.3) 360 (20.0) 0.6 (0.5-0.8) 
     Respiratory Conditions     
          Respiratory Infections 1172 (34.6) 647 (40.6) 525 (29.3) 1.7 (1.5-2.0) 
          COPD 628 (18.5) 260 (16.3) 368 (20.5) 0.8 (0.7-0.9) 
          Asthma 310 (9.1) 135 (8.5) 175 (9.8) 0.8 (0.7-1.1) 
          Other (e.g., Pleurisy, Respiratory 
Failure) 
1891 (55.8) 955 (59.9) 936 (52.2) 1.5 (1.3-1.7) 
     Gastrointestinal (GI) Conditions     
         Upper or Lower GI Disorders 1740 (51.4) 905 (56.8) 835 (46.5) 1.6 (1.4-1.8) 
         Other (e.g., Gastroenteritis, Constipation) 1886 (55.7) 1016 (63.7) 870 (48.5) 2.0 (1.7-2.3) 
     Musculoskeletal     
         Arthritis 1266 (37.4) 546 (34.3) 720 (40.1) 0.8 (0.7-0.9) 
         Back Conditionsb 642 (18.9) 221 (13.9) 421 (23.5) 0.5 (0.4-0.6) 
         Osteoporosis 550 (16.2) 364 (22.8) 186 (10.4) 2.9 (2.4-3.6) 
     Injuries     
         Fractures 563 (16.6) 304 (19.1) 259 (14.4) 1.5 (1.2-1.8) 
         Poisoning  85 (2.5) 41 (2.6) 44 (2.5) 0.9 (0.6-1.4) 
Mental Health     
     Mood Disorders 1292 (38.1) 572 (35.9) 720 (40.1) 0.8 (0.7-0.9) 
     Anxiety Disordersc 1347 (39.8) 631 (39.6) 716 (39.9) 1.0 (0.8-1.1) 
     Personality Disorders 102 (3.0) 38 (2.4) 64 (3.6) 0.6 (0.4-0.9) 
     Suicidal Ideation or Intentional Self-Injury 140 (4.1) 39 (2.4) 101 (5.6) 0.4 (0.3-0.6) 
     Substance Use Disorders 327 (9.7) 82 (5.1) 245 (13.7) 0.3 (0.2-0.4) 
     Schizophrenia and Psychotic Disorders 685 (20.2) 367 (23.0) 318 (17.7) 1.3 (1.1-1.6) 
     Cognitive Disordersd 922 (27.2) 440 (27.6) 482 (26.9) 1.3 (1.1-1.5) 
     Sleep Disorders  59 (1.7) 27 (1.7) 32 (1.8) 0.9 (0.5-1.6) 
     Attention Deficit Disorders  69 (2.0) 13 (0.8) 56 (3.1) 0.3 (0.1-0.5) 
aAdjusted for sex, age, race/ethnicity, rural residence, estimated household income, and duration of 
observation 
bIncludes spondylosis, intervertebral disc disorders, and “other” back problems  
cIncludes obsessive compulsive disorders, generalized anxiety disorder, phobias, post-traumatic stress 
disorder, and other anxiety disorders 
dIncludes delirium, dementia, amnesia, and “other” cognitive disorders 
Abbreviations: ID = Intellectual disability; OR = Odds ratio; COPD = Chronic obstructive pulmonary 
disease 
 
 
 
